The Drugs Controller General of India (DCGI) has approved the emergency use of drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderate to severe Covid-19 patients. It has been developed by Institute of Nuclear Medicine and Allied Sciences (Inmas), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories, Hyderabad. … Continue reading DCGI gives emergency approval to anti-Covid drug 2-DG developed by DRDO